PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)

Clinical trials for PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL) explained in plain language.

Never miss a new study

Get alerted when new PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL) trials appear

Sign up with your email to follow new studies for PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope to stop deadly leukemia relapse after transplant

Disease control Not yet recruiting

This study tests whether adding a new drug called asciminib to standard maintenance therapy can better prevent leukemia from returning after a stem cell transplant. Researchers will compare two groups: one receiving the standard drug alone and another receiving the standard drug …

Matched conditions: PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)

Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)

Get alerted when new PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL) trials appear

New hope to stop deadly leukemia relapse after transplant